25
total announcements
BROOKS.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹203 Cr
P/E (TTM)
15.3
EPS (TTM)
₹4.49
52W Low
₹36.90
52W High
₹129.35
Dividend Yield
0.00%
Beta
1.15
Price / Book
1.7
Debt / Equity
6.9
Revenue (TTM)
₹83 Cr
Gross Margin
41.44%
Operating Margin
6.30%
Brooks Laboratories Ltd
Brooks Laboratories Ltd has approved a Scheme of Arrangement for the demerger of its Manufacturing Business into a wholly-owned subsidiary, Abridge Speciality Limited. The demerger is subject to regulatory approvals and shareholder approval.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the outcome of its Board Meeting, where it approved a Scheme of Arrangement for the demerger of its Manufacturing Business into a wholly-owned subsidiary, Abridge Speciality Limited. The demerger is subject to regulatory approvals and shareholder approval.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has responded to a clarification sought by BSE regarding the movement in its share price, stating that it has disclosed all material information and is not aware of the reason for the price change.
Brooks Laboratories Ltd
The BSE has sought clarification from Brooks Laboratories Ltd regarding significant price movement, to ensure investors have relevant information and to safeguard their interests.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has provided a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September 2026.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the closure of its trading window for insiders from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
BROOKS LABORATORIES LIMITED
Brooks Laboratories Limited has informed BSE about the cessation of its Company Secretary and Compliance Officer.
BROOKS LABORATORIES LIMITED
Brooks Laboratories Limited has informed the BSE about the cessation of its Company Secretary and Compliance Officer.
Brooks Laboratories Ltd
Brooks Laboratories Ltd announced the resignation of Ms. Krutika Rane as Company Secretary and Compliance Officer, effective October 9, 2026, to pursue an alternate career opportunity.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has published a newspaper advertisement regarding the re-lodgement of transfer requests of physical shares, as per SEBI Circular No. HO/38/13/11(2)/2026-MIRSD-POD/I/3750/2026, in compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Brooks Laboratories Ltd
Brooks Laboratories Ltd held its 24th Annual General Meeting (AGM) on September 3, 2026, through video conferencing. The meeting was attended by 319 members, and the requisite quorum was present. The AGM approved various resolutions, including the adoption of annual audited standalone and consolidated financial statements, the appointment of a director, and the ratification of remuneration of cost auditors and related party transactions.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has published an addendum to the notice of its 24th Annual General Meeting, which was scheduled to be held on September 3, 2026. The addendum was published in the Financial Express and Jansatta newspapers on August 22, 2026. The company's registered office and works are located in Baddi, Himachal Pradesh.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has issued an addendum to the notice of its 24th Annual General Meeting, amending Resolution No. 4 and its explanatory statement regarding a corporate guarantee arrangement. The addendum is available on the company's website and will be considered for all future references.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has issued an addendum to the notice of its 24th Annual General Meeting, updating Resolution No. 4 and its explanatory statement regarding a corporate guarantee arrangement.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the record date, e-voting dates, and book closure date for its 24th Annual General Meeting. The book closure period will be from August 27, 2026, to September 3, 2026, and the e-voting period will be from August 31, 2026, to September 2, 2026.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has published unaudited financial results for the quarter ended 30th June 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 141.86 lakhs and a loss of Rs. 178.69 lakhs for the consolidated entity.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, showing a net profit of Rs. 141.86 lakhs and earnings per share of Rs. 0.48.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced the publication of a notice in newspapers regarding the 24th Annual General Meeting (AGM) to be held on September 3, 2026, through video conference or other audio-visual means.
Brooks Laboratories Ltd
Brooks Laboratories Ltd has announced its Annual Report for the FY 2025-26 and scheduled its 24th Annual General Meeting (AGM) to be held on September 3, 2026. The company has also requested shareholders to update their KYC details and dematerialize physical securities.